(IN BRIEF) Sanofi has agreed to acquire UK-based Vicebio for $1.15 billion upfront plus up to $450 million in milestones, with closing anticipated in Q4 2025. The deal adds an early-stage bivalent RSV/hMPV vaccine (VXB‑241, in Phase 1 for older adults) and … Read the full press release
Posted in Artificial Intelligence (AI), Business, Financial, France, Government, Healthcare, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science, Security & Safety, Technology, United Kingdom
Tagged acquisition, AI-powered biopharma, Daniel Watterson, Emmanuel Hanon, fully liquid combination vaccines, Jean-François Toussaint, Keith Chappell, lower respiratory tract infections, Medicxi, Molecular Clamp technology, non-mRNA vaccine, Older Adults, partnership, Paul Young, pneumonia, prefilled syringes, regulatory approvals, respiratory vaccines pipeline, seasonal surges, Tags: Sanofi, UniQuest, University of Queensland, Vicebio
(IN BRIEF) The European Society of Cardiology’s new Clinical Consensus Statement, published on 3 June 2025 in the European Heart Journal, positions vaccination as a core component of cardiovascular prevention. It reviews evidence that infections such as influenza, pneumonia, SARS-CoV-2, … Read the full press release
Posted in Business, Financial, France, Healthcare, Industrial, Investment, Management, Marketing, News, Non Profit, Science, Technology
Tagged ACC/AHA guidelines, ACVC, cardiovascular prevention, EAPC, ESC Clinical Consensus Statement, European Heart Journal, European Society of Cardiology, heart failure, HFA, influenza, major adverse cardiovascular events, myocarditis, pneumonia, preventive cardiology, respiratory syncytial virus, SARS-CoV-2, Thomas F. Lüscher, vaccination
(IN BRIEF) Researchers at the Technical University of Munich (TUM) have developed an inhalable RNA-based drug that targets macrophages, overactive immune cells often responsible for lung damage in diseases like Covid-19. The drug, RCS-21, inhibits the activity of microRNA 21, … Read the full press release
Posted in Business, Education, Germany, Healthcare, Industrial, Management, News, Pharma & Biotech, Science
Tagged Christina Beck, Inhalable, macrophages, medicine, microRNA 21, pneumonia, RCS-21, RNA Drug, RNATICS, Severe Lung Inflammation, Stefan Engelhardt, Technical University of Munich, trimannose, wellness
SOPHIA ANTIPOLIS, 07-Aug-2017 — /EuropaWire/ — Pneumonia or sepsis in adults that results in hospital admission is associated with a six-fold increased risk of cardiovascular disease in the first year, according to research published today in the European Journal of Preventive … Read the full press release
OXFORD, 05-Aug-2016 — /EuropaWire/ — Oxford researchers are developing a tool to make it much easier and cheaper to diagnose pneumonia – the number one killer of children under 5. Their latest research is published in Journal of the Royal Society … Read the full press release
Posted in Education, Healthcare, Science, United Kingdom
Tagged Elina Naydenova, Oxford University, pneumonia
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?